Nicholas Hawkins Sells 221,035 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CFO Nicholas Hawkins sold 221,035 shares of the company’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $33.40, for a total value of $7,382,569.00. Following the transaction, the chief financial officer owned 110,600 shares in the company, valued at $3,694,040. This trade represents a 66.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Arteris Trading Down 9.7%

NASDAQ:AIP traded down $3.63 during trading hours on Friday, reaching $33.71. 1,727,606 shares of the stock were exchanged, compared to its average volume of 996,540. The company has a quick ratio of 1.13, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The business has a 50-day moving average of $21.50 and a two-hundred day moving average of $17.58. Arteris, Inc. has a twelve month low of $6.88 and a twelve month high of $38.47. The company has a market capitalization of $1.56 billion, a price-to-earnings ratio of -42.67 and a beta of 1.93.

Arteris (NASDAQ:AIPGet Free Report) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million for the quarter, compared to analyst estimates of $21.03 million. On average, equities analysts predict that Arteris, Inc. will post -0.68 EPS for the current year.

Wall Street Analysts Forecast Growth

AIP has been the topic of several analyst reports. TD Cowen increased their price objective on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday. Weiss Ratings cut Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday. Northland Securities set a $38.00 price objective on Arteris in a research note on Wednesday. Rosenblatt Securities increased their price objective on Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, Wall Street Zen cut Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $37.75.

Check Out Our Latest Analysis on Arteris

Hedge Funds Weigh In On Arteris

Several large investors have recently bought and sold shares of the business. Needham Investment Management LLC increased its holdings in Arteris by 2.6% in the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock valued at $52,878,000 after buying an additional 86,500 shares during the last quarter. Franklin Resources Inc. increased its holdings in Arteris by 6.2% in the fourth quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock valued at $27,017,000 after buying an additional 101,646 shares during the last quarter. Vanguard Group Inc. increased its holdings in Arteris by 8.2% in the third quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company’s stock valued at $16,103,000 after buying an additional 120,947 shares during the last quarter. Westerly Capital Management LLC increased its holdings in Arteris by 109.6% in the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after buying an additional 745,000 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in Arteris by 144.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after buying an additional 598,840 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company’s stock.

About Arteris

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.